Laukien Frank H's Form 4/A amendment
AmendedBruker Corp (BRKR) · filed May 17, 2022
- Accession no.
- 0001415889-22-005134
- Filed
- May 17, 2022
- Trade date
- May 11, 2022
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- May 16, 2022
This filing lists 1 non-derivative transaction. Open-market purchases total $98.6K. It was filed 6 days after the trade.
This amendment replaces 0001415889-22-005013 (filed May 16, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Laukien Frank HCIK 0001133649 | Director, Officer (PRESIDENT & CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | Common Stock | PPurchaseAcquired | +1,710 | $57.64F1 | +$98,564.4 | 38,476,233 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.30 to $57.98, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
The reporting person disclaims beneficial ownership of 1,046,499 shares held by the reporting person's former spouse- Robyn Laukien, 492 shares held by the reporting person's former spouse- Ruta Laukien, 337,087 shares held by the reporting person's adult son and 336,607 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Remarks
The purchases reported on the original Form 4 filed on May 16, 2022 were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), with sales of shares by the reporting person on February 18, 2022. The reporting person has made arrangements with Bruker Corporation to voluntarily disgorge the full amount of statutory 'profit' calculated pursuant to Section 16(b) of the Exchange Act.